Analysts See $0.27 EPS for Bio-Rad Laboratories, Inc. (BIO); Lombard Odier Asset Management Switzerland Sa Has Trimmed Its Danaher Del (DHR) Position

Analysts expect Bio-Rad Laboratories, Inc. (NYSE:BIO) to report $0.27 EPS on May, 4 after the close.They anticipate $0.15 EPS change or 35.71% from last quarter’s $0.42 EPS. BIO’s profit would be $8.05M giving it 204.26 P/E if the $0.27 EPS is correct. After having $1.25 EPS previously, Bio-Rad Laboratories, Inc.’s analysts see -78.40% EPS growth. The stock increased 0.27% or $0.59 during the last trading session, reaching $220.6. About shares traded. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 37.86% since September 26, 2016 and is uptrending. It has outperformed by 26.44% the S&P500.

Lombard Odier Asset Management Switzerland Sa decreased Danaher Corp Del (DHR) stake by 8.7% reported in 2016Q4 SEC filing. Lombard Odier Asset Management Switzerland Sa sold 20,000 shares as Danaher Corp Del (DHR)’s stock declined 0.19%. The Lombard Odier Asset Management Switzerland Sa holds 210,000 shares with $16.35M value, down from 230,000 last quarter. Danaher Corp Del now has $57.47 billion valuation. The stock decreased 0.16% or $0.13 during the last trading session, reaching $83. About shares traded. Danaher Corporation (NYSE:DHR) has risen 8.36% since September 26, 2016 and is uptrending. It has underperformed by 3.06% the S&P500.

Among 3 analysts covering Bio-Rad Laboratories (NYSE:BIO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Bio-Rad Laboratories had 8 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) has “Buy” rating given on Wednesday, September 7 by Jefferies. On Thursday, October 13 the stock rating was initiated by CL King with “Buy”. As per Friday, April 28, the company rating was maintained by Jefferies. Jefferies maintained the stock with “Buy” rating in Wednesday, April 12 report.

Investors sentiment increased to 1.17 in 2016 Q4. Its up 0.09, from 1.08 in 2016Q3. It improved, as 25 investors sold Bio-Rad Laboratories, Inc. shares while 73 reduced holdings. 39 funds opened positions while 76 raised stakes. 18.93 million shares or 3.35% more from 18.31 million shares in 2016Q3 were reported. Point72 Asset Mgmt Lp accumulated 0.02% or 12,700 shares. Epoch Invest Partners Inc holds 0.17% or 247,608 shares. Us Retail Bank De stated it has 0% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Granahan Inv Mgmt Ma owns 1.1% invested in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 175,234 shares. Louisiana-based Louisiana State Employees Retirement Sys has invested 0.05% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Bluecrest Cap Ltd, Guernsey-based fund reported 66,270 shares. Panagora Asset Mgmt accumulated 1,194 shares. Btr Capital Mgmt Incorporated reported 3,190 shares or 0.12% of all its holdings. Invesco Ltd invested 0% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Renaissance Tech Lc holds 0.01% or 31,200 shares. Corvex Mngmt Limited Partnership reported 1.53% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Ubs Asset Management Americas reported 466,785 shares. Select Equity Gp Lp invested 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Bessemer Gru has 39 shares. Dynamic Cap Management Ltd has invested 0.14% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO).

Since November 4, 2016, it had 0 insider purchases, and 4 insider sales for $1.85 million activity. Magni Giovanni had sold 4,498 shares worth $881,300 on Monday, March 6. $37,596 worth of Bio-Rad Laboratories, Inc. (NYSE:BIO) was sold by HERTIA JOHN on Friday, November 4. $222,675 worth of Bio-Rad Laboratories, Inc. (NYSE:BIO) was sold by STARK JAMES R on Wednesday, November 9. $13,912 worth of Bio-Rad Laboratories, Inc. (NYSE:BIO) was sold by Hall Shannon. $687,189 worth of Bio-Rad Laboratories, Inc. (NYSE:BIO) was sold by GOETZ JOHN. Another trade for 88 shares valued at $14,575 was made by Crowley Michael on Friday, November 4.

Bio-Rad Laboratories, Inc. is a maker and distributor of its life science research and clinical diagnostics products. The company has market cap of $6.58 billion. The Firm operates through two divisions: Life Science and Clinical Diagnostics. It has a 232.42 P/E ratio. It makes and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Analysts await Danaher Corporation (NYSE:DHR) to report earnings on July, 24. They expect $0.97 earnings per share, down 22.40% or $0.28 from last year’s $1.25 per share. DHR’s profit will be $671.64M for 21.39 P/E if the $0.97 EPS becomes a reality. After $0.85 actual earnings per share reported by Danaher Corporation for the previous quarter, Wall Street now forecasts 14.12% EPS growth.

Investors sentiment increased to 1.34 in Q4 2016. Its up 0.03, from 1.31 in 2016Q3. It is positive, as 55 investors sold DHR shares while 315 reduced holdings. 89 funds opened positions while 406 raised stakes. 508.19 million shares or 0.53% more from 505.49 million shares in 2016Q3 were reported. Bedrijfstakpensioenfonds Voor De Media Pno holds 0.13% or 12,700 shares in its portfolio. Farr Miller Washington Limited Co Dc has invested 2.09% in Danaher Corporation (NYSE:DHR). Lipe & Dalton owns 41,811 shares or 2.32% of their US portfolio. Boston Private Wealth Lc accumulated 195,318 shares. Davidson Inv Advisors has 0% invested in Danaher Corporation (NYSE:DHR). Sterling Invest Management Inc holds 0.64% or 5,770 shares. Hikari Tsushin accumulated 1.41% or 59,835 shares. Bb&T invested in 30,781 shares or 0.05% of the stock. Mai Capital Management has 0.13% invested in Danaher Corporation (NYSE:DHR). Mcmillion Capital Management Inc has invested 1.23% in Danaher Corporation (NYSE:DHR). Iowa-based Cambridge Investment Inc has invested 0.02% in Danaher Corporation (NYSE:DHR). Menta Limited Liability Corp holds 4,534 shares or 0.03% of its portfolio. Invest Service Wi has invested 3.1% of its portfolio in Danaher Corporation (NYSE:DHR). 20,341 are held by Condor Management. Pension invested in 417,214 shares.

Since February 1, 2017, it had 0 insider purchases, and 11 selling transactions for $35.01 million activity. Lalor Angela S had sold 6,044 shares worth $521,017. Joyce Thomas Patrick JR sold $16.44 million worth of stock or 196,309 shares. 34,168 shares were sold by LUTZ ROBERT S, worth $2.87 million on Wednesday, February 1. LOHR WALTER G also sold $891,937 worth of Danaher Corporation (NYSE:DHR) on Wednesday, February 15. Shares for $84,533 were sold by Ellis Brian W on Tuesday, February 28. Shares for $2.87M were sold by Raskas Daniel. EHRLICH DONALD J sold $888,340 worth of stock.

Lombard Odier Asset Management Switzerland Sa increased Ulta Salon Cosmetcs & Frag I (NASDAQ:ULTA) stake by 21,000 shares to 35,000 valued at $8.92 million in 2016Q4. It also upped Liberty Interactive Llc (Prn) stake by 330,000 shares and now owns 420,000 shares. Integra Lifesciences Hldgs C (NASDAQ:IART) was raised too.

Among 14 analysts covering Danaher Corporation (NYSE:DHR), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Danaher Corporation had 46 analyst reports since July 28, 2015 according to SRatingsIntel. RBC Capital Markets maintained Danaher Corporation (NYSE:DHR) on Wednesday, September 9 with “Sector Perform” rating. The rating was maintained by Barclays Capital on Monday, April 18 with “Overweight”. Goldman Sachs downgraded it to “Neutral” rating and $103 target in Tuesday, December 8 report. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, October 23. As per Thursday, January 21, the company rating was initiated by Citigroup. The rating was reinitiated by Morgan Stanley on Tuesday, December 13 with “Overweight”. The firm has “Overweight” rating by Barclays Capital given on Wednesday, September 7. Stifel Nicolaus maintained the shares of DHR in report on Thursday, October 1 with “Buy” rating. Citigroup upgraded the stock to “Buy” rating in Friday, February 24 report. The company was maintained on Friday, October 23 by Barclays Capital.